Recent News

Latest GeoVax News

  • Home
    Home This is where you can find all the blog posts throughout the site.
  • Categories
    Categories Displays a list of categories from this blog.
  • Tags
    Tags Displays a list of tags that have been used in the blog.
277
ATLANTA, GA, March 27, 2019 – GeoVax Labs, Inc. (OTCQB: GOVX), a biotechnology company developing human vaccines, today announced its financial results for the year ended...
Last modified on Continue reading
981
GeoVax Ebola Vaccine Provides Potential for 100% Protection from Single-Dose ATLANTA, GA, March 19, 2019 – GeoVax Labs, Inc. (OTCQB: GOVX), a biotechnology company developing human...
Last modified on Continue reading
378
Selection in Two Award Categories follows GeoVax receiving the 2018 Best Biotech Award ATLANTA, GA, March 12, 2019 – GeoVax Labs, Inc. (OTCQB: GOVX), a biotechnology...
Last modified on Continue reading
928
ATLANTA, GA, March 11, 2019 – GeoVax Labs, Inc. (OTCQB: GOVX), a biotechnology company developing human vaccines and immunotherapies using its novel viral vector platform technology,...
Last modified on Continue reading
1314
Supported by Contract from U.S. Agency for International Development (USAID) ATLANTA, GA, March 4, 2019 – GeoVax Labs, Inc. (OTCQB: GOVX), a biotechnology company developing human...
Last modified on Continue reading